<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteMechanobiology &#8211; Wyss Institute</title>
		<link>https://wyss.stage.a17.io</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 30 Jul 2026 21:38:59 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.stage.a17.io/discipline/mechanobiology/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>Wyss Institute promotes Natalie Artzi to its Core Faculty and appoints Di Feng as an Associate Faculty member</title>
				<link>https://wyss.stage.a17.io/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/</link>
        <pubDate>Mon, 12 Aug 2024 13:15:25 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Beth Israel Deaconess Medical Center]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[Di Feng]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Natalie Artzi]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40759</guid>
                            <description>Artzi’s promotion and Feng’s appointment strengthen the Institute’s efforts in nanomedicine and immunoengineering, as well as modeling of chronic kidney diseases</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Natalie Artzi, Ph.D., joined the ranks of the Wyss Institute&rsquo;s now 12 Core Faculty members after only two years as an Associate Faculty member. Artzi&rsquo;s promotion reflects her exceptional commitment to the Institute&rsquo;s mission and the deep engagements and collaborations she has initiated within its technology development community. The Wyss Institute also warmly&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/</link>
          <title>In August, we announced <a href="https://wyss.harvard.edu/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/">Natalie Artzi’s promotion to Core Faculty member and the appointment of Di Feng</a> as an Associate Faculty member. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/08/08145256/ArtziFengComposite.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=1c298d6dde25ec80aa1f9fe30f99b0fd"/></url>
				</image>
        			</item>

		
			<item>
				<title>Human cervix modeled in microfluidic organ chip fills key women&#8217;s health gap</title>
				<link>https://wyss.stage.a17.io/news/human-cervix-modeled-in-microfluidic-organ-chip-fills-key-womens-health-gap/</link>
        <pubDate>Fri, 31 May 2024 14:55:29 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40143</guid>
                            <description>Engineered cervix with in vivo-like mucus production, hormone sensitivity, and associated microbiome creates novel testbed for bacterial vaginosis therapeutics and other treatments</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Bacterial Vaginosis (BV) has been identified as one of the many unmet needs in women&rsquo;s health and affects more than 25% of reproductive&#x2d;aged women. It is caused by pathogenic bacteria that push the healthy microbiomes in the female vagina and cervix &ndash; the small gatekeeper canal that connects the uteruns and vagina &ndash; into a state of imbalance known as dysbiosis.</p>
<p><a href="https://wyss.stage.a17.io/news/human-cervix-modeled-in-microfluidic-organ-chip-fills-key-womens-health-gap/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/human-cervix-modeled-in-microfluidic-organ-chip-fills-key-womens-health-gap/</link>
          <title>Wyss researchers have developed a human Cervix-on-a-Chip that models the complex cervix tissue in vitro, and overcomes major limitations of existing animal and <em>in vitro</em> models to enable the study of bacterial vaginosis and development of drugs. Credit: Shutterstock</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/05/30093346/shutterstock_2079694981.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=dfc20f21950dd60f95918a0dfeac8694"/></url>
				</image>
        			</item>

		
			<item>
				<title>Expanding a lymph node, boosting a vaccine</title>
				<link>https://wyss.stage.a17.io/news/expanding-a-lymph-node-boosting-a-vaccine/</link>
        <pubDate>Mon, 06 May 2024 09:15:39 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomaterials]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cancer Vaccine]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=39890</guid>
                            <description>A biomaterial vaccine enhances and sustains lymph node expansion following vaccination, boosting anti-tumor immunity in an animal model</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Each one of us has around 600 lymph nodes (LNs) &ndash; small, bean&#x2d;shaped organs that house various types of blood cells and filter lymph fluid &ndash; scattered throughout our bodies. Many of us have also experienced some of our LNs to temporarily swelling during infections with viruses or other pathogens. This LN expansion and subsequent contraction can also result from&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/expanding-a-lymph-node-boosting-a-vaccine/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/expanding-a-lymph-node-boosting-a-vaccine/</link>
          <title>This immunofluorescent staining shows a lymph node that has been significantly expanded in mice with the help of the biomaterial MPS-vaccine (on the right), next to a lymph node taken from non-treated control mice (on the left) at the same time post-vaccination. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/05/01142936/lymph-node-staining-001.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=ca5c0dcbfb6b24c6b94244fb5015a90b"/></url>
				</image>
        			</item>

		
			<item>
				<title>MyoExo: Wearable Muscle-Centric Sensors for Improved Assessment of Neurological Disorders</title>
				<link>https://wyss.stage.a17.io/technology/myoexo-smart-wearable-sensors-for-parkinsons-disease/</link>
        <pubDate>Wed, 01 May 2024 14:00:27 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Bioinspired Soft Robotics]]></category>
		<category><![CDATA[Biomechanics]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Conor Walsh]]></category>
		<category><![CDATA[Exosuit]]></category>
		<category><![CDATA[Muscle]]></category>
		<category><![CDATA[Parkinson’s disease]]></category>
		<category><![CDATA[Robert Wood]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=32175</guid>
                                                <content:encoded><![CDATA[<p>Abnormal changes in muscle function are hallmarks of a collection of neurological disorders, including Parkinson&rsquo;s Disease (PD), essential tremor, epilepsy, certain sleep disorders, and others. For example, patients with PD can have slowed movements (bradykinesia), tremors, and muscle stiffness (rigidity) &ndash; doctors need to detect at least two of the three signs for a positive diagnosis.</p>
<p><a href="https://wyss.stage.a17.io/technology/myoexo-smart-wearable-sensors-for-parkinsons-disease/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/myoexo-smart-wearable-sensors-for-parkinsons-disease/</link>
          <title>This ultra-sensitive resilient strain sensor can be embedded in textiles and soft robotic systems. Credit: Oluwaseun Araromi/Harvard SEAS</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2020/11/10161331/Sensor_Twist.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=8a6d3af2c8931576f7d14f67ab0c41a8"/></url>
				</image>
        			</item>

		
			<item>
				<title>Repairing patients’ dura more durably</title>
				<link>https://wyss.stage.a17.io/news/repairing-patients-dura-more-durably/</link>
        <pubDate>Wed, 20 Mar 2024 17:55:14 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[Brain Injury]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=39492</guid>
                            <description>Highly adhesive and mechanically strong Dural Tough Adhesive addresses multiple limitations in the repair of the dural membrane lining the brain and spinal cord after trauma and surgeries</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The dural membrane (dura) is the outermost of three meningeal layers that line the central nervous system (CNS), which includes the brain and spinal cord. Together, the meninges function as a shock&#x2d;absorber to protect the CNS against trauma, circulate nutrients throughout the CNS, as well as remove waste. The dura also is a critical biological barrier that&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/repairing-patients-dura-more-durably/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/repairing-patients-dura-more-durably/</link>
          <title>A research collaboration of bioengineers and neurosurgeons has developed a new solution to re-sealing the dura that, using a multi-functional biomaterial, addresses key limitations of current repair methods. Credit: Peter Allen, Ryan Allen, and James C. Weaver. SEAS/MIT/Wyss</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/03/19161756/Dural-Tough-Adhesive-on-Brain-Tissue.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=4ee342604151b7e167b293e746f51219"/></url>
				</image>
        			</item>

		
			<item>
				<title>Soft robotic, wearable device improves walking for individual with Parkinson’s disease</title>
				<link>https://wyss.stage.a17.io/news/soft-robotic-wearable-device-improves-walking-for-individual-with-parkinsons-disease/</link>
        <pubDate>Fri, 05 Jan 2024 14:21:45 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Assistive Devices]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Conor Walsh]]></category>
		<category><![CDATA[Gait Control]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Soft Robotics]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=38710</guid>
                            <description>Robotic exosuit eliminated gait freezing, a common and highly debilitating symptom </description>
                                        <content:encoded><![CDATA[<p>By Leah Burrows / SEAS Communications (CAMBRIDGE, Mass.) &mdash; Freezing is one of the most common and debilitating symptoms of Parkinson&rsquo;s disease, a neurodegenerative disorder that affects more than 9 million people worldwide. When individuals with Parkinson&rsquo;s disease freeze, they suddenly lose the ability to move their feet, often mid&#x2d;stride, resulting in a series of staccato stutter steps that&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/soft-robotic-wearable-device-improves-walking-for-individual-with-parkinsons-disease/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/soft-robotic-wearable-device-improves-walking-for-individual-with-parkinsons-disease/</link>
          <title>This next-generation version of the suit is in development and could pave the way for new systems to help individuals with Parkinson's regain their independence. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/01/04154533/New-Hip-Shots.pptx.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=6dcefdcaf7cd21c84d29ce5fd1203096"/></url>
				</image>
        			</item>

		
			<item>
				<title>The Wyss Institute&#8217;s 2023-2024 Validation Projects</title>
				<link>https://wyss.stage.a17.io/news/the-wyss-institutes-2023-2024-validation-projects/</link>
        <pubDate>Thu, 19 Oct 2023 14:47:13 +0000</pubDate>
        <dc:creator><![CDATA[Seth Kroll]]></dc:creator>
        		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=37800</guid>
                            <description>13 projects selected to receive Validation Project support to advance commercialization and impact</description>
                                        <content:encoded><![CDATA[<p>Each year we name a class of Validation Projects whose teams receive dedicated funding, business development support, and additional resources to advance their technologies towards commercialization. Over the course of the year, project teams pursue initial use&#x2d;cases for their technologies that have the potential for significant positive impact. They also collaborate with key opinion leaders&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/the-wyss-institutes-2023-2024-validation-projects/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/the-wyss-institutes-2023-2024-validation-projects/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/07/31105458/HarborSite-Team-0469_Final.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=be4985fe4121bd6050761dce0a53eb30"/></url>
				</image>
        			</item>

		
			<item>
				<title>Adding immunity to human kidney-on-a-chip advances cancer drug testing</title>
				<link>https://wyss.stage.a17.io/news/adding-immunity-to-human-kidney-on-a-chip-advances-cancer-drug-testing/</link>
        <pubDate>Wed, 23 Aug 2023 14:57:37 +0000</pubDate>
        <dc:creator><![CDATA[Seth Kroll]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=37512</guid>
                            <description>An immune-infiltrated human kidney organoid-on-chip model enables assessment of kidney toxicities to immunotherapeutic T cell bispecific antibody drugs with high resolution</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (Boston) &mdash; A growing repertoire of cell and molecule&#x2d;based immunotherapies is offering patients with indomitable cancers new hope by mobilizing their immune systems against tumor cells. An emerging class of such immunotherapeutics, known as T cell bispecific antibodies (TCBs), are of growing importance with several TCBs that the U.S. Food and Drug Administration (FDA)&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/adding-immunity-to-human-kidney-on-a-chip-advances-cancer-drug-testing/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/adding-immunity-to-human-kidney-on-a-chip-advances-cancer-drug-testing/</link>
          <title>The team’s study demonstrated in a novel immune-infiltrated human kidney organoid-on-chip model that a T cell bispecific antibody (TCB) targeting an antigen from the Wilms tumor-1 protein (WT1-TCB) specifically recruits immune cells, including cytotoxic T cells (shown in green), to clusters of podocytes (shown in blue), leading to their destruction. The grey staining is derived from dying cells. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/08/22163738/Kidney-organoid-on-chip.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=d47559348b52211470cb82f9a9d11ed3"/></url>
				</image>
        			</item>

		
			<item>
				<title>Bridging science, engineering, and art: from mechanobiology to Human Organs-on-Chips</title>
				<link>https://wyss.stage.a17.io/media-post/bridging-science-engineering-and-art-from-mechanobiology-to-human-organs-on-chips/</link>
        <pubDate>Thu, 27 Jul 2023 17:49:31 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Donald E. Ingber]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=37346</guid>
                                                <content:encoded><![CDATA[<p>In this Marsilius Lecture, Wyss Founding Director Don Ingber shares his personal path from a serendipitous experience in an undergraduate art class that led to his discovery of how living cells are constructed using &ldquo;tensegrity&rdquo; architecture and how this contributed to the birth of the field of Mechanobiology to his more recent work on human Organ Chips, which offer the possibility of replacing&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/bridging-science-engineering-and-art-from-mechanobiology-to-human-organs-on-chips/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/bridging-science-engineering-and-art-from-mechanobiology-to-human-organs-on-chips/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2016/08/05170244/Donald_Ingber_headshot_1500x1000-2.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=34efc8ea707d68cf2f9254617814d096"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wearable Technology for True Movement Quantification</title>
				<link>https://wyss.stage.a17.io/technology/wurq/</link>
        <pubDate>Wed, 19 Apr 2023 20:47:43 +0000</pubDate>
        <dc:creator><![CDATA[admin]]></dc:creator>
        		<category><![CDATA[Assistive Devices]]></category>
		<category><![CDATA[Athletic]]></category>
		<category><![CDATA[Bioinspired Soft Robotics]]></category>
		<category><![CDATA[Biomechanics]]></category>
		<category><![CDATA[Biosensors]]></category>
		<category><![CDATA[Conor Walsh]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=23612</guid>
                            <description>Wyss startup <a href="https://www.wurq.io/" target="_blank">WurQ</a> launched in 2023 to bring AI and exercise science to existing wearables to quantify physical work, and assess the amount, quality, and intensity. </description>
                                        <content:encoded><![CDATA[<p>Athletes undergoing daily training and patients undergoing physical therapy, often do not have a way to quantitatively assess their progress or obtain actionable insights that help to enhance performance or avoid injuries. There are vast options for wearable devices and activity monitors, however, those are generally limited to tracking cardiovascular activities and heart&#x2d;related data.</p>
<p><a href="https://wyss.stage.a17.io/technology/wurq/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/wurq/</link>
          <title>Credit: WurQ</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2020/02/19182355/WurQ-System-on-Athelete-01519_Final.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=b6319d38935d7fcd43519c8b6b4a4977"/></url>
				</image>
        			</item>

			</channel>
</rss>
